Skip to content

The Global Prevalence of Vitamin A Deficiency in Populations at Risk

5 min read

According to the World Health Organization, vitamin A deficiency (VAD) affects an estimated 190 million preschool-age children worldwide, primarily in Africa and Southeast Asia. This staggering statistic highlights a critical public health crisis, demanding a deeper understanding of the global prevalence of vitamin A deficiency in populations at risk.

Quick Summary

This article examines the worldwide distribution and trends of vitamin A deficiency, focusing on the most affected regions and vulnerable demographics, including children and pregnant women.

Key Points

  • Prevalence Varies by Region: The highest prevalence of vitamin A deficiency (VAD) is concentrated in Sub-Saharan Africa and South Asia, while it is rare in high-income countries.

  • Children are a High-Risk Group: Young children, especially those aged 6–59 months, are highly vulnerable due to increased growth needs and a high incidence of infectious diseases.

  • Impact on Maternal Health: Pregnant and lactating women are also at significant risk, as deficiency can impact their own health and the vitamin A status of their infants.

  • Leading Cause of Childhood Blindness: VAD is the single most important cause of preventable childhood blindness globally, and also increases morbidity and mortality from infections.

  • Multi-Strategy Interventions are Key: Effective strategies to combat VAD include high-dose supplementation programs, food fortification, dietary diversification, and improved nutrition education.

  • Poverty and Infections Exacerbate Deficiency: In low-income settings, inadequate dietary intake combined with frequent infections like diarrhea and measles create a vicious cycle of vitamin A depletion.

In This Article

Understanding the Landscape of Vitamin A Deficiency

Vitamin A deficiency (VAD) is a serious public health concern, with insufficient dietary intake and high rates of infection acting as primary drivers, particularly in low- and middle-income countries (LMICs). In higher-income nations, clinical VAD is rare, often linked to underlying health conditions that affect fat absorption, such as cystic fibrosis or inflammatory bowel diseases. The consequences of VAD are severe, ranging from impaired immune function and increased susceptibility to infections like measles and diarrhea to visual impairment, including night blindness and irreversible blindness.

Populations Most Vulnerable to VAD

Several demographic groups are disproportionately affected by VAD. These populations often face combined challenges of poverty, food insecurity, and limited access to healthcare.

  • Young Children: Infants and preschool-aged children are particularly vulnerable due to rapid growth, which increases their vitamin A requirements. Children with VAD have compromised immune systems, making them more susceptible to infectious diseases, and are at a higher risk of mortality from common childhood illnesses. A 2023 study showed that approximately 14.73% of children and adolescents in LMICs were affected by VAD in 2019.
  • Pregnant and Lactating Women: Pregnant women have an increased need for vitamin A to support fetal growth and their own metabolic needs. The vitamin A content in the breast milk of deficient mothers is often too low to meet an infant's needs, perpetuating the cycle of deficiency. Subclinical VAD is widespread among women of childbearing age in many developing regions.
  • Individuals with Malabsorption Issues: Conditions that interfere with the body's ability to absorb fat-soluble vitamins, including cystic fibrosis, Crohn's disease, and celiac disease, place individuals at a high risk for VAD.
  • Displaced Populations: Individuals in refugee settlements and displaced populations are frequently at high risk for VAD due to humanitarian crises that disrupt food supply and healthcare services.

Geographical Burden and Trends

The burden of VAD is not uniform across the globe. Recent studies and reports from organizations like the WHO highlight distinct geographical patterns.

VAD in Sub-Saharan Africa and South Asia

Sub-Saharan Africa and South Asia consistently show the highest prevalence rates of VAD. A 2023 study noted that in 2019, the low socioeconomic development index (SDI) region, which includes much of Sub-Saharan Africa, had a VAD prevalence rate among children of almost 30%, nearly five times higher than the high-middle SDI region. In 2013, 95% of deaths attributable to VAD occurred in these two regions. Factors contributing to this high burden include diets that are low in animal products, poverty, and high rates of infectious diseases.

Trends and Intervention Strategies

Despite the persistent challenges in some areas, there has been a significant reduction in VAD-related mortality in LMICs over recent decades, thanks to global efforts, especially high-dose vitamin A supplementation (VAS) programs. However, the progress has been uneven. While mortality has decreased, some regions like Sub-Saharan Africa have not seen significant improvements in VAD morbidities. In contrast, some countries in East and Southeast Asia have achieved significant reductions in VAD prevalence. The continued implementation of VAS programs, coupled with food fortification and dietary diversification, remains crucial.

Comparison of Regional VAD Prevalence (2019)

Region (WHO) Prevalence (0-18 years) Severe Public Health Concern Key Factors Intervention Efficacy
Africa (AFR) 24.51% Severe (0-5 years, 6-12 years) Poverty, infectious disease, low food diversity Modest improvements in morbidity despite mortality reduction
South-East Asia (SEAR) 13.11% Moderate (0-12 years) Poverty, reliance on plant-based foods, persistent subclinical VAD Significant reduction in clinical cases, challenges with coverage
Americas (AMR) 9.07% Mild to No Problem Higher SDI, better access to nutrients Deficiency mainly tied to specific health conditions
Europe (EUR) 5.89% No public health problem High SDI, diverse diets, food fortification Very low prevalence, specific cases linked to malabsorption
Eastern Mediterranean (EMR) 17.43% Moderate (0-12 years) Economic disparities, conflict, potential increasing burden Data availability challenges persist
Western Pacific (WPR) 8.36% Varies by sub-region Diverse regional and economic factors Significant reductions in prevalence in East Asia

Moving Forward: Addressing the Global Challenge

Despite global progress in reducing VAD-related mortality, the prevalence of this deficiency remains a significant challenge, particularly in the most vulnerable regions. Sustainable interventions must go beyond emergency supplementation and address the underlying causes of VAD.

  • Dietary Diversification: Promoting the cultivation and consumption of vitamin A-rich foods, including fruits, vegetables, and animal products, is a long-term solution. This requires agricultural support and community education.
  • Food Fortification: The fortification of staple foods like vegetable oil and cereal-based products is a highly effective, population-wide strategy for increasing vitamin A intake. This approach has proven successful in many countries.
  • Nutrition Education: Raising awareness among mothers and communities about the importance of a vitamin A-rich diet and the symptoms of VAD is essential for prevention and early detection.
  • Improved Health Infrastructure: Ensuring access to healthcare, including robust immunization programs and proper sanitation, can reduce the prevalence of infectious diseases that deplete vitamin A stores. Regular deworming and safe water supplies are also vital components.

In conclusion, while progress has been made in controlling VAD mortality, the global prevalence of vitamin A deficiency continues to place millions at risk, with the burden falling heaviest on children and women in Sub-Saharan Africa and South Asia. A multi-pronged strategy encompassing supplementation, fortification, dietary diversification, and improved public health infrastructure is necessary to achieve lasting and equitable improvements in vitamin A status worldwide.

For more information on nutritional programs, consult the World Health Organization's nutrition data via the WHO's Vitamin and Mineral Nutrition Information System.

Factors Influencing the Global Burden

The persistence of VAD in low-income settings is influenced by a complex interplay of socioeconomic and environmental factors. For example, low maternal education levels correlate with lower rates of vitamin A supplementation in children, as seen in Bangladesh. The economic status of a household also directly impacts access to nutritious food. Poorer households, particularly in rural areas, consistently show higher rates of deficiency compared to richer, urban populations. The environment also plays a role, with certain agroecological zones or regions with poor sanitation showing higher prevalence rates due to issues with food production and infectious diseases. These interconnected issues underscore the need for integrated, multi-sectoral approaches that address not only diet but also public health and education to effectively combat VAD.

Frequently Asked Questions

The earliest and most common sign of VAD is night blindness (nyctalopia), which is the inability to see well in low light. More severe symptoms, known collectively as xerophthalmia, can progress to vision loss and permanent blindness. Other signs include increased susceptibility to infections, skin problems, and impaired growth.

Children in developing countries are at higher risk due to a combination of factors. Their diets often lack adequate sources of vitamin A, and they are more frequently exposed to infectious diseases like measles and diarrhea, which deplete vitamin A stores. Rapid growth also increases their nutritional needs.

One of the most widespread global strategies is high-dose vitamin A supplementation (VAS) programs, particularly targeting children aged 6 to 59 months. This approach is recommended by the WHO in areas where VAD is a public health problem and has been shown to reduce mortality.

Socioeconomic status is a major determinant of VAD. Lower-income populations often lack the resources for a nutrient-rich, diverse diet that includes adequate animal products or fortified foods. In contrast, VAD is extremely rare in high-income countries with better food access and healthcare.

Yes, VAD can be treated through vitamin A supplementation. In cases of severe deficiency or clinical symptoms like xerophthalmia, higher doses are administered. For milder cases, dietary improvement is the primary focus. Supplementation is highly effective in reducing childhood morbidity and mortality in deficient populations.

The WHO classifies the public health significance of VAD based on its prevalence. A prevalence of serum retinol below 0.70 μmol/L in 20% or more of preschool children indicates a 'severe' public health problem, while 10-19% is 'moderate'.

Alongside supplementation, prevention relies on a multi-pronged approach. This includes encouraging dietary diversity with vitamin A-rich foods, implementing food fortification programs, improving public health education, and addressing infectious diseases and sanitation issues.

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.